Skincare Industry Leader MED-ACNE.COM Announces Rollout of Innovative Acne Treatment Product Onto International Market

Daniel Les, president and CEO of Med-Acne.com, announced from the company's headquarters today the international roll out of an acne treatment product that previously has only been available on a more limited basis in select countries. With the announcement by Les, Med-Acne.com, through its Internet based retail outlet, is now making Kamille Zinci widely available to adults and young people alike who require acne treatment products.

"One of the groups of people that we are targeting are those men and women as well as teenagers who have not found any acne treatment to be particularly successful. Kamille Zinci, a product the originally was used by people seeking a reliable acne solution in Germany, works on ridding a person's skin of different bacteria that, if allowed to fester, aggravate and worsen an acne condition," Les explained. "Although we are making a special effort to reach out to those people who have problem acne, Kamille Zinci actually can be useful for people who do not have stubborn condition. It is formulated to resolve mild and moderate cases of acne as well as severe conditions."

Although acne is a treatable disease, research studies indicate that over 40% of those afflicted with acne do not obtain any type of treatment whatsoever. Research regarding the manner in which people of all ages respond to and treat acne reveals that:

- 11% will see a physician
- 20% will go to a skin care center
- 30% will use an over-the-counter medication from a drug store or pharmacy
- Over 40% will do nothing

"We feel that Kamille Zinci will be attractive to people who presently use no treatment at all for their acne," Les remarked. "Unlike some regimens that actually are rather complicated and time consuming, with Kamille Zinci, a person afflicted with acne has only to apply the treatment once a day before bedtime."

For more information, visit med-acne.com

Obagi Expands Product Line with Clenziderm for Acne

Obagi has introduced a new product to aid in the fight against acne - CLENZIderm M.D.™ Acne Therapeutic System. This new product is the first to be infused with the groundbreaking liquefied 5% benzoyl peroxide technology that delivers astonishing results.

The CLENZIderm M.D.™ Acne Kit is the first of its kind to effectively treat all three causes of acne. It quickly gets rid of excess sebum, skin cell buildup, and Proprionibacterium acnes bacteria. After a 3 week clinical study, CLENZIderm M.D.™ provided a reduction in sore red acne by 62% and a reduction in blackheads and whiteheads by 47%.

The secret is behind Obagi's patented Soluzyl Technology™ which converts the active ingredient of Benzoyl Peroxide into a liquid upon contact with the skin. By becoming a liquid on contact, the solution is able to penetrate deeper into the pores and provide rapid acne lesion reduction. This new acne solution could mean a complete transformation in acne products and ingredients. Most acne solutions are only able to clean the surface of the skin. Benzoyl Peroxides are typically formulated with insoluble macro-crystals. These macro-crystals are too big to dig deep into the pores which results in only cleansing the surface of the skin. Obagi's patented Soluzyl Technology™ liquefies these macro-crystals to allow them to clean deeper into the pores.

Obagi boasted during the unveiling of the results from their clinical trials. They emphasized that the use of CLENZIderm M.D.™ shows follicular acne reduction as quickly as eight hours. Their findings also show a 52% reduction in inflammatory lesions and a 34% reduction in non-inflammatory lesions in two weeks.

Obagi's CLENZIderm M.D.™ Acne Therapeutic System is an amazing advancement in skin care - one that may revolutionize your skin to looking cleaner and better.

For more information, visit prskincare.com